Esch B, Raptis G
Behring Krankenhaus, Schering AG, Berlin.
Z Hautkr. 1989 Dec 15;64(12):1135-8.
In a clinical study on decubital ulcers, 95 patients in 10 hospitals were treated with dextranomer and crilanomer. The size of the ulcer surface and the physician's evaluation of the healing status at the end of treatment served as the most important criteria for our assessment of the curative effect. Both preparations proved equivalent in the statistical test. Crilanomer revealed slightly better results than dextranomer with regard to the physician's overall evaluation al well as odor, exudation, and cleansing. Both modes of treatment were accompanied by local incompatibility reactions of a minor degree; there were no systemic side effects in either preparation.
在一项关于压疮的临床研究中，10家医院的95名患者接受了右旋糖酐omer和crilanomer治疗。溃疡表面大小以及治疗结束时医生对愈合状况的评估是我们评估疗效的最重要标准。两种制剂在统计检验中被证明等效。在医生的总体评估以及气味、渗出物和清洁方面，crilanomer的效果略优于右旋糖酐omer。两种治疗方式均伴有轻微程度的局部不相容反应；两种制剂均未出现全身副作用。
